4-AMINO-N-((3S)-2,3-DIHYDRO-6-(TRIFLUOROMETHYL)-3-BENZOFURANYL)-N-(1-METHYL-1H-PYRAZOL-4-YL)IMIDAZO(1,5-A)QUINOXALINE-8-CARBOXAMIDE
UNII PX24Q9TN7E
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-amino-n-((3s)-2,3-dihydro-6-(trifluoromethyl)-3-benzofuranyl)-n-(1-methyl-1h-pyrazol-4-yl)imidazo(1,5-a)quinoxaline-8-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) PX24Q9TN7E.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3028983-48-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C24H18F3N7O2 DKFVCXAEBYPKRD-HXUWFJFHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-amino-n-((3s)-2,3-dihydro-6-(trifluoromethyl)-3-benzofuranyl)-n-(1-methyl-1h-pyrazol-4-yl)imidazo(1,5-a)quinoxaline-8-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.